Literature DB >> 4030566

Influence of nicotine in cigarette smoke on acute ventilatory responses in awake dogs.

L Y Lee, R F Morton, D T Frazier.   

Abstract

To determine whether the acute ventilatory responses to inhaled cigarette smoke are affected by a difference in nicotine level, control cigarettes (low-nicotine research cigarettes) were laced with nicotine to generate an increase of 330% (mean) in nicotine content with little or no change in the levels of other smoke constituents. Acute ventilatory responses to both control and nicotine-laced cigarettes were determined and compared in six awake chronic dogs. Spontaneous inhalation of nicotine-laced cigarette smoke (10% concn, 750 ml vol) via a tracheostomy tube caused distinct and consistent changes in breathing pattern on the first or second breath of inhaled smoke: an apnea in three dogs, an augmented inspiration in two dogs, and rapid shallow breathing in one dog. No significant change in breathing pattern was found immediately following inhalation of control cigarette smoke. Both types of cigarettes caused a delayed hyperpnea. However, the increase in minute ventilation induced by nicotine-laced cigarettes (from a base line of 2.8 to a peak of 25.7 l/min) was significantly greater than that by control cigarettes (from 2.9 to 5.5 l/min). Results of this study suggest that nicotine is responsible for the elicitation of both the immediate and delayed ventilatory responses to inhaled cigarette smoke generated under our experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030566     DOI: 10.1152/jappl.1985.59.1.229

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  3 in total

1.  Bronchoconstriction and apnea induced by cigarette smoke: nicotine dose dependence.

Authors:  E R Beck; R F Taylor; L Y Lee; D T Frazier
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  Evidence for Alpha7 Nicotinic Receptor Activation During the Cough Suppressing Effects Induced by Nicotine and Identification of ATA-101 as a Potential Novel Therapy for the Treatment of Chronic Cough.

Authors:  Brendan J Canning; Qi Liu; Mayuko Tao; Robert DeVita; Michael Perelman; Douglas W Hay; Peter V Dicpinigaitis; Jing Liang
Journal:  J Pharmacol Exp Ther       Date:  2021-11-15       Impact factor: 4.402

Review 3.  Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance.

Authors:  Lloyd Tanner; Andrew Bruce Single
Journal:  J Innate Immun       Date:  2019-09-17       Impact factor: 7.349

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.